Search by Drug Name or NDC
NDC 00093-3213-05 Clonazepam 2 mg/1 Details
Clonazepam 2 mg/1
Clonazepam is a ORAL TABLET in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Teva Pharmaceuticals USA, Inc.. The primary component is CLONAZEPAM.
MedlinePlus Drug Summary
Clonazepam is used alone or in combination with other medications to control certain types of seizures. It is also used to relieve panic attacks (sudden, unexpected attacks of extreme fear and worry about these attacks). Clonazepam is in a class of medications called benzodiazepines. It works by decreasing abnormal electrical activity in the brain.
Related Packages: 00093-3213-05Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Clonazepam
Product Information
| NDC | 00093-3213 |
|---|---|
| Product ID | 0093-3213_d6abe4e3-7699-4ead-95f4-739a961b23ad |
| Associated GPIs | 72100010000315 |
| GCN Sequence Number | 004562 |
| GCN Sequence Number Description | clonazepam TABLET 2 MG ORAL |
| HIC3 | H4A |
| HIC3 Description | ANTICONVULSANT - BENZODIAZEPINE TYPE |
| GCN | 17472 |
| HICL Sequence Number | 001894 |
| HICL Sequence Number Description | CLONAZEPAM |
| Brand/Generic | Generic |
| Proprietary Name | Clonazepam |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | Clonazepam |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | TABLET |
| Route | ORAL |
| Active Ingredient Strength | 2 |
| Active Ingredient Units | mg/1 |
| Substance Name | CLONAZEPAM |
| Labeler Name | Teva Pharmaceuticals USA, Inc. |
| Pharmaceutical Class | Benzodiazepine [EPC], Benzodiazepines [CS] |
| DEA Schedule | CIV |
| Marketing Category | ANDA |
| Application Number | ANDA074569 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00093-3213-05 (00093321305)
| NDC Package Code | 0093-3213-05 |
|---|---|
| Billing NDC | 00093321305 |
| Package | 500 TABLET in 1 BOTTLE (0093-3213-05) |
| Marketing Start Date | 1998-08-24 |
| NDC Exclude Flag | N |
| Pricing Information | |
| Price Per Unit | 0.04639 |
| Pricing Unit | EA |
| Effective Date | 2024-02-21 |
| NDC Description | CLONAZEPAM 2 MG TABLET |
| Pharmacy Type Indicator | C/I |
| OTC | N |
| Explanation Code | 1 |
| Classification for Rate Setting | G |
| As of Date | 2024-02-21 |
This pricing file, entitled the NADAC (National Average Drug Acquisition
Cost) files, provide
state Medicaid agencies with covered outpatient drug prices by averaging
survey invoice
prices from retail community pharmacies across the United States. These
pharmacies include
independent retail community pharmacies and chain pharmacies. The prices
are updated on a
weekly and monthly basis